Last Posted: Apr 11, 2019
- HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
Sartore-Bianchi Andrea et al. The oncologist 2019 Apr - Response to "Colorectal Cancer Screening by Stool DNA Testing and Patient Emotional Health".
Eckmann Jason D et al. The American journal of gastroenterology 2019 Apr - Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee Jong Lyul et al. World journal of gastroenterology 2019 Mar 25(11) 1341-1354 - Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
Feliubadaló Lídia et al. International journal of cancer 2019 Mar - Single-center study of Lynch syndrome screening in colorectal polyps.
Zhu FangChao et al. Hereditary cancer in clinical practice 2019 179 - Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.
Cini Giulia et al. Molecular genetics & genomic medicine 2019 Mar e587 - Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
Wirbel Jakob et al. Nature medicine 2019 Apr - Clinical implications of the genetics of sporadic colorectal cancer.
Fischer Jesse et al. ANZ journal of surgery 2019 Mar - Management of genetically determined colorectal cancer.
Clark S K et al. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2019 Mar - Update on small bowel surveillance in hereditary colorectal cancer syndromes.
Sanchez-Mete Lupe et al. Tumori 2019 Feb 105(1) 12-21
.png)
No hay comentarios:
Publicar un comentario